These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7025162)

  • 21. Results of HBsAg testing of AABB-CAP survey samples.
    Polesky HF; Hanson MR
    Am J Clin Pathol; 1977 Jul; 68(1 Suppl):210-2. PubMed ID: 879096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HBs antigen screening with Groupamatic. Inhibition of passive hemagglutination and latex test].
    Soulier JP; Garretta M; Benamon D; Drouet J; Courouce-Pauty AM
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):511-21. PubMed ID: 675004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity and specificity of Czechoslovak ELISA HBsAg Sevac tests: comparison with other third-generation tests and counter-immunoelectrophoresis.
    Mancal P; Benda R; König J; Helm R; Nĕmecek V; Kyselová M
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):425-35. PubMed ID: 6363532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of enzyme immunoassay with radioimmunoassay for the detection of hepatitis B surface antigen.
    Hendry RM; Herzog LW; Herrman JE; Meehan RE
    J Med Microbiol; 1983 May; 16(2):111-6. PubMed ID: 6341594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research on HBsAg: comparison between two methods of the third generation, RPHA and IEA].
    Moretti R; Vujovic A; Benda N
    Quad Sclavo Diagn; 1982 Jun; 18(2):209-14. PubMed ID: 6762575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of enzyme immunoassay (EIA) as a screening method for hepatitis B markers in an open population.
    McCready JA; Morens D; Fields HA; Coleman PJ; Kane M; Schatz G
    Epidemiol Infect; 1991 Dec; 107(3):673-84. PubMed ID: 1752314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A retrospective study of HBsAG carriers in the blood bank of Navarra].
    Medarde A; del Hierro J; Aramburu E; Esquíroz P; Martínez JL
    Rev Med Univ Navarra; 1988; 32(4):209-16. PubMed ID: 3155332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid determination of hepatitis B surface antigen (HBsAg) by latex agglutination using an integrating sphere turbidimetric assay.
    Yamashiki M; Nishimura A; Kishioka H; Takase K; Kosaka Y
    J Immunol Methods; 1993 Feb; 158(2):251-6. PubMed ID: 8429229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of technics of screening of carriers of HBs antigen].
    Simonneau M; Ayed K; Terrier E; Jaulmes B
    Rev Fr Transfus Immunohematol; 1976 Sep; 19(3):461-70. PubMed ID: 1006054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of HBsAg in screening donors].
    Wang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Dec; 10(6):363-5. PubMed ID: 2624939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the radioimmunological and immunoenzymatic methods in detection of HBsAg].
    Nocera A; Barocci S
    Boll Soc Ital Biol Sper; 1979 Nov; 55(22):2337-40. PubMed ID: 398703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of HBsAg carrier rate in acute viral hepatitis and high risk individuals using RPHA and ELISA.
    Korgaonkar A; Verenkar MP; Savio R; Pinto MJ; Singh I
    Indian J Pathol Microbiol; 1996 Oct; 39(4):277-80. PubMed ID: 9009478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.
    Jongerius JM; Wester M; Cuypers HT; van Oostendorp WR; Lelie PN; van der Poel CL; van Leeuwen EF
    Transfusion; 1998 Jan; 38(1):56-9. PubMed ID: 9482395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experiences with an enzyme-immunoassay for hepatitis B antigen detection in blood donors (author's transl)].
    Seidl S; Kühner J; Trautmann L; Pade K
    Klin Wochenschr; 1978 May; 56(10):521-4. PubMed ID: 349257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chimera antibody erythroimmunoassay for detecting HBsAg in human sera.
    Chen Y; Yang SC; Luo QH
    Res Virol; 1990; 141(3):337-42. PubMed ID: 2203124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved detection of hepatitis B surface antigen (HBsAg) in blood donors by monoclonal radioimmunoassay.
    Ben-Porath E; Wands JR; Bar-Shany S; Huggins C; Isselbacher K
    Transfusion; 1985; 25(1):10-4. PubMed ID: 3969695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests.
    Castiglione G; Zappa M; Grazzini G; Rubeca T; Turco P; Sani C; Ciatto S
    J Med Screen; 2000; 7(1):35-7. PubMed ID: 10807145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A latex agglutination test for hepatitis type B antigen.
    Brammer KW; Leach JM; Butt WD
    Dev Biol Stand; 1975; 30():58-67. PubMed ID: 1204975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies of the distribution of hepatitis B markers among blood donors and patients with post-transfusion hepatitis in the city of Sofia].
    Gubev E; Rashkov R; Dimitrova T; Sharankov N; Andonov A
    Vutr Boles; 1987; 26(3):38-43. PubMed ID: 3617705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of passive hemagglutination, solid-phase radioimmunoassay, and immunoelectroosmophoresis for the detection of hepatitis B antigen.
    Peterson DA; Froesner GG; Deinhardt FW
    Appl Microbiol; 1973 Sep; 26(3):376-80. PubMed ID: 4796164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.